Investigating Internists’ Endocrinologists’ and Paediatricians’ Attitudes in Regards to the VALUE of Innovative Diabetes Mellitus Self-Monitoring Technologies in Greece

Author(s)

Siskou O1, Galanis P2, Konstantakopoulou O3, Karagkouni I3, Bargiota A4, Benroubi M5, Christoforidis A6, Delis D7, Didangelos T6, Dimitriadis G8, Doupis J9, Galli-Tsinopoulou A6, Ioannidis I10, Kanaka-Gantenbein C8, Kotsa K6, Koutsovasilis A11, Lambadiari V8, Papagianni M4, Papadimitriou DT12, Pappas A13, Souvatzoglou M14, Tentolouris N15, Tigas S16, Tsimihodimos V16, Mouslech Z17, Tsapas A18, Vazaiou A7, Vryonidou A19, Kaitelidou D8
1Center for Health Services Management and Evaluation, Nursing Department, National and Kapodistrian University of Athens, ATHENS, Greece, 2Center for Health Services Management and Evaluation, Nursing Department,National and Kapodistrian University of Athens, Athens, Greece, 3Center for Health Services Management and Evaluation, Nursing Department, National and Kapodistrian University of Athens, Athens, Greece, 4University of Thessaly, Larissa, Greece, 5Euroclinic General Hospital, Athens, Greece, 6Aristotle University of Thessaloniki, Thessaloniki, Greece, 7Panagiotis and Aglaia Kyriakou Children’s Hospital, Athens, Greece, 8National and Kapodistrian University of Athens, Athens, Greece, 9Diabetes Department and Clinical Research Center, Iatriko Palaiou Falirou Medical Center, Athens, Greece, 10Konstantopouleio General Hospital of Patisia, Athens, Greece, 11Diabetes Center, Saint Panteleimon General Hospital of Nikaia, Piraeus, Greece, 12Athens Medical Center, Athens, Greece, 13Venizelio General Hospital, Iraklion, Greece, 14Private Outpatient Clinic, Athens, Greece, 15National Kapodistrian University of Athens, Athens, Greece, 16University of Ioannina, Ioannina, Greece, 17Private Outpatient Clinic, Thessaloniki, Greece, 18Aristotle University Thessaloniki, Thessaloniki, Greece, 19Red Cross General Hospital, Athens, Greece

Presentation Documents

OBJECTIVES : Innovative technologies of continuous glucose monitoring (CGM) and flash glucose monitoring (FGM) contribute significantly to metabolic control and improve quality of life of diabetic patients. In this study, the attitudes of expert physicians regarding the value of innovative glucose self-monitoring technologies in Greece were investigated.

METHODS : Two Advisory Boards (AdB) were set up by Key Opinion Leaders-KOLs (from Academia, National Health System Hospitals and Private Sector): the first consisted of Internists/ Diabetologists (N = 12) and the second consisted of Endocrinologists/Pediatricians (N = 11). Participants were asked to complete a structured questionnaire developed by experts on health services research, in which answers were given through a five-point Likert scale. A common data analysis (taken into consideration both internists/ diabetologists and endocrinologists/pediatricians answers) was conducted using the SPSS.20v.

RESULTS : The vast majority of participants (96%) recognized the importance of innovative self-monitoring technologies for the effective management of diabetes mellitus (DM) and was willing to use them in their clinical practice. In particular, 96% of physicians considered as quite/very important the Ambulatory Glucose Profile (AGP) report provided by the FGM technology. Moreover, participants reported that FGM technology contributes to reducing fluctuations in glucose levels (100%), increasing the time in range (TIR) and reducing the time in hypoglycemia (96% of participants). Additionally, the majority of physicians (87%) stated that FGM technology contributes to achieving savings by reducing complications.Thus, 84% of physicians considered FGM technology should be reimbursed for patients with DM2, in addition to patients with DM1.However, participants highlighted the need for further development and improvements of FGM technology (e.g measurement accuracy at off charts values)

CONCLUSIONS : The vast majority of participants considered the FGM technology as of high value and consequently recommended its coverage by social security schemes for patients with DM

Conference/Value in Health Info

2021-05, ISPOR 2021, Montreal, Canada

Value in Health, Volume 24, Issue 5, S1 (May 2021)

Code

PDB23

Topic

Health Policy & Regulatory, Health Service Delivery & Process of Care, Medical Technologies

Topic Subcategory

Diagnostics & Imaging, Disease Management, Insurance Systems & National Health Care, Reimbursement & Access Policy

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×